A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia
- PMID: 11493466
- DOI: 10.1182/blood.v98.4.1166
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia
Abstract
The hematopoietic stem cell underlying acute myeloid leukemia (AML) is controversial. Flow cytometry and the DNA-binding dye Hoechst 33342 were previously used to identify a distinct subset of murine hematopoietic stem cells, termed the side population (SP), which rapidly expels Hoechst dye and can reconstitute the bone marrow of lethally irradiated mice. Here, the prevalence and pathogenic role of SP cells in human AML were investigated. Such cells were found in the bone marrow of more than 80% of 61 patients and had a predominant CD34(low/-) immunophenotype. Importantly, they carried cytogenetic markers of AML in all 11 cases of active disease examined and in 2 out of 5 cases in complete hematological remission. Comparison of daunorubicin and mitoxantrone fluorescence emission profiles revealed significantly higher drug efflux from leukemic SP cells than from non-SP cells. Three of 28 SP cell transplants generated overt AML-like disease in nonobese diabetic--severe combined immunodeficient mice. Low but persistent numbers of leukemic SP cells were detected by molecular and immunological assays in half of the remaining mice. Taken together, these findings indicate that SP cells are frequently involved in human AML and may be a target for leukemic transformation. They also suggest a mechanism by which SP cells could escape the effects of cytostatic drugs and might eventually contribute to leukemia relapse. (Blood. 2001;98:1166-1173)
Similar articles
-
Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia.Blood. 2001 Jun 15;97(12):3882-9. doi: 10.1182/blood.v97.12.3882. Blood. 2001. PMID: 11389030
-
Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry.Blood. 1995 Apr 15;85(8):2147-53. Blood. 1995. PMID: 7536492
-
Heterogeneity of isolated mononuclear cells from patients with acute myeloid leukemia affects cellular accumulation and efflux of daunorubicin.Haematologica. 2000 Feb;85(2):124-32. Haematologica. 2000. PMID: 10681718
-
[Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].Folia Med Cracov. 2001;42(3):5-80. Folia Med Cracov. 2001. PMID: 12353422 Review. Polish.
-
A systematic overview of chemotherapy effects in acute myeloid leukaemia.Acta Oncol. 2001;40(2-3):231-52. doi: 10.1080/02841860151116321. Acta Oncol. 2001. PMID: 11441935 Review.
Cited by
-
The proportion of CD34(+)CD38(low or neg) myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemia.Leukemia. 2013 Mar;27(3):728-31. doi: 10.1038/leu.2012.217. Epub 2012 Jul 31. Leukemia. 2013. PMID: 22926686 Free PMC article. No abstract available.
-
High affinity and covalent-binding microtubule stabilizing agents show activity in chemotherapy-resistant acute myeloid leukemia cells.Cancer Lett. 2015 Nov 1;368(1):97-104. doi: 10.1016/j.canlet.2015.07.038. Epub 2015 Aug 12. Cancer Lett. 2015. PMID: 26277539 Free PMC article.
-
DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer.Clin Cancer Res. 2022 May 2;28(9):1948-1965. doi: 10.1158/1078-0432.CCR-21-1299. Clin Cancer Res. 2022. PMID: 35135840 Free PMC article.
-
Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.Clin Cancer Res. 2008 May 1;14(9):2813-23. doi: 10.1158/1078-0432.CCR-07-1528. Clin Cancer Res. 2008. PMID: 18451249 Free PMC article.
-
Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.Mol Cancer. 2011 Sep 14;10:112. doi: 10.1186/1476-4598-10-112. Mol Cancer. 2011. PMID: 21917149 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical